The global Prostate Health Market, valued at USD 34.05 billion in 2022, is anticipated to witness significant growth, reaching USD 66.86 billion by 2030. This growth reflects an impressive Compound Annual Growth Rate (CAGR) of 8.8% over the forecast period of 2023-2030.The prostate health market encompasses a range of products and services aimed at addressing various prostate-related...
The global Prostate Health Market is experiencing a surge, with a projected market size of USD 66.86 billion by 2030. This significant increase from USD 34.05 billion in 2022 reflects a Compound Annual Growth Rate (CAGR) of 8.8% over the forecast period (2023-2030).
KEY PLAYERS:
The Major key players are Astellas Pharma, Eli lilly and Company, Glaxo smithkline, Abbott...